Metabolism Assays Market worth $2.1 billion by 2028

Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Assay Kits and reagents segment is expected to account for the larger share in 2022.

The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents dominated the products market and are also estimated to grow at the highest CAGR during the forecast period. The large share is due to the recurrence of assay kits & reagents and easy availability.

The diagnostic segment held the largest market share in the metabolism assay market.

By application, the global metabolism assay market is broadly segmented into diagnostics and research. The diagnostics segment accounted for the larger share of the market in 2022. The diagnostics segment is also estimated to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed to various factors, such as the growing number of obese population and the growing number of hospitals which are important end users for metabolism assays.

North America dominates the global metabolism assay market.

Based on the region, the metabolism assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North American market is driven by well-established pharmaceutical and biotechnology industry, investments around drug discovery and toxicity testing. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. The presence of a large population base coupled with large patient population and increasing rate of obesity are some of the major factors driving the growth of this regional market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=135163479&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Metabolism Assays Market Dynamics:

Drivers:

1. Increasing funding and investments in metabolic research

Restraints:

1. High cost of metabolism assay analyzers

Opportunities:

1. Integration with wearable devices

Challenge:

1. Complexity of assay development

Key Market Players:

Major players in metabolism assays market include Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), and Kaneka Eurogentec S.A. (Belgium).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=135163479&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.